Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Knowing when to revisit budget categories helps you rebalance spending before it wrecks your plan.
17,280 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Tesla stock can swing on headlines and catalysts. This guide shows you how to decide whether you should wait tesla st...
Stocks closed higher for an eighth straight week as earnings buoy sentiment, even as a key consumer confidence gauge ...
Texas’ GOP Senate runoff pits Sen. John Cornyn against Ken Paxton as Trump weighs in, boosting a race already fueled ...
A Texas primary shock sends markets into a risk-off mode as sen. john cornyn becomes a flashpoint for party fault lin...
NVIDIA stock struggled over the last week despite solid earnings. This guide breaks down the reasons behind the move ...
Markets react to policy chatter that a former president invested in Intel and the stock soared. Now investors are wat...
When a famous entertainer pulls out of an event over misrepresentation, budgets, sponsors, and fans all feel the ripp...
NVIDIA sits atop market caps, but size isn’t the same as influence. This article breaks down what 'largest' means, wh...
Solana has faced headwinds, but many investors wonder if solana about have biggest could finally arrive in the second...
A high-profile CEO champions self-taught, AI-fluent leadership while leaning on a deep bench of scientists. The piece...
A growing spotlight on disabled adult child benefits is reshaping family planning. DAC payments, typically about half...